Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01011426 · ClinicalTrials.gov registry record · Phase 2
Bisacodyl Use in the Post-operative Care of Obstetrical/Gynecological (OB/GYN) Patients
A Phase 2 study, sponsored by The Cooper Health System.
- Completed
- Registry status
- Phase 2
- Development phase
- 285
- Enrollment target
NCT01011426: Completed Phase 2 study, sponsored by The Cooper Health System.
NCT01011426 is a Phase 2 study that has completed, run by The Cooper Health System. The registered enrollment target is 285 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (114% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01011426, a Phase 2 study, has completed, sponsored by The Cooper Health System.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 285 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether Bisacodyl, 5 mg usage decreases the incidence of nausea and abdominal pain after surgery, and also decreases the number of hospitalization days.
Interventions
- DRUG placebo
- DRUG Bisacodyl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 285 participants |
| Start Date | 2009-04 |
| Est. Completion | 2012-06 |
| Phase | Phase 2 |
What the finished NCT01011426 record still lists
NCT01011426 is an interventional study that assigns participants to a tested intervention. The registered 285 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (114% higher).
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT01011426 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01011426 about?
NCT01011426 is a clinical study titled "Bisacodyl Use in the Post-operative Care of Obstetrical/Gynecological (OB/GYN) Patients". The purpose of this study is to determine whether Bisacodyl, 5 mg usage decreases the incidence of nausea and abdominal pain after surgery, and also decreases the number of hospitalization days.
What is the current status of trial NCT01011426?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 285 participants. The study started on 2009-04. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01011426?
The interventions under investigation include: placebo (DRUG), Bisacodyl (DRUG).
Who is sponsoring clinical trial NCT01011426?
This trial is sponsored by The Cooper Health System, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01011426's enrollment target sits among peer trials
285 192nd of 2000 higher than 1,806 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03412877 · 285 participants · Phase 2
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
- NCT04537936 · 285 participants · NA
Psychotherapy Intervention for Latinos With Adv Cancer
- NCT04965675 · 285 participants · Phase 3
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
- NCT05320835 · 285 participants · NA
A Setting Focus Overdose Prevention Intervention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia